Skip to main content

Table 2 The laboratory findings of study population

From: Prognostic value of rising mean platelet volume during hospitalization in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Variable Survivor
(n = 370)
Non-survivor
(n = 110)
P value
Total cholesterol (mg/dl) 181 ± 43 163 ± 39 0.001
SCra adm (mg/dl) 0.86 (0.76–1.02) 0.95 (0.80–1.26) 0.048
Hemoglobin (g/dl) 14.0 ± 1.2 13.2 ± 2.2 <  0.001
WBC count (103/mm3) 12 ± 4 12 ± 5 0.781
Platelets adm(103/mm3) 273 ± 78 271 ± 93 0.846
Platelets 48-72h (103/mm3) 241 ± 73 235 ± 90 0.448
MPV adm ((fL) 9.0 ± 1.6 9.0 ± 1.3 0.648
MPV48-72h (fL) 9.4 ± 1.6 9.8 ± 1.4 0.035
ΔMPVa (fL) 0.37 (− 0.1–0.89) 0.79 (0.30–1.40) <  0.001
LVEF (%) 45 ± 9 41 ± 10 <  0.001
  1. Abbreviations: LVEF left ventricular ejection fraction, SCr serum creatinine at admission, MPV mean platelet volume, ΔMPV change in mean platelet volume, WBC; white blood cell
  2. aComparison was made using Mann-Whitney U test at P <  0.05, and these values were described by median with inter-quartile range (25th and 75th percentile)